Clinical Trials Browser

INDUSTRY × 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid × Clear all

NCT05849298 2026-03-03

PSMACare

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT07084909 2025-12-10

HARRIER

Phase 2/3 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06074510 2025-09-11

MIRROR

Phase 4 Active not recruiting

Prostatic Neoplasms

NCT02981368 2021-08-09

OSPREY

Phase 2/3 Completed

385 enrolled 20 charts

Disease, Prostatic Neoplasms